Name
PRESENTATION: Targeted Protein Degraders:From Discovery to the Clinic.
Date & Time
Tuesday, February 16, 2021, 11:40 AM - 12:05 PM
Speakers
Description
A case study of the predictive capability of C4T’s TORPEDO™ platform in the development of novel, selective, orally bioavailable degraders of a protein target called BRD9, including C4T’s development candidate, CFT8634 for synovial sarcoma and SMARCB1-deleted solid tumors.
Virtual Session Link